LYPSAGEMS Financial Results
- Market cap
- ₹1.5 lakh crore
- P/E
- 22.5
- P/B
- 3.20
- ROE
- 16.4%
- Dividend yield
- 1.20%
- 52-week range
- ₹2,100.00 – ₹2,900.00
For the year ended FY26, LYPSAGEMS reported revenue of ₹16,850 crore and net profit of , against ₹14,500 crore and a year earlier.
LYPSAGEMS annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | FY26 | FY25 | FY24 |
|---|---|---|---|
| Revenue | 16,850 | 14,500 | 12,800 |
| Expenses | — | — | — |
| Operating profit | — | — | — |
| Operating margin % | — | — | — |
| Other income | — | — | — |
| Interest | — | — | — |
| Depreciation | — | — | — |
| Profit before tax | — | — | — |
| Tax % | — | — | — |
| Net profit | — | — | — |
| EPS (₹) | 56.40 | 47.70 | 41.00 |
| Dividend payout % | — | — | — |
Source: Company filings, in ₹ crore. How this data is compiled.
LYPSAGEMS financial results — frequently asked questions
What is LYPSAGEMS's annual revenue and net profit?
For the financial year ended FY26, LYPSAGEMS's revenue was ₹16,850 crore and net profit .
What is the EPS of LYPSAGEMS?
Annual EPS for FY26 was ₹56.40.
Are these figures consolidated or standalone?
They are the figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade LYPSAGEMS With ATS
Track LYPSAGEMS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.